Instructions to Authors  by unknown
1. Manuscript Submission
Manuscripts (meaning all submission items, 
including all text, tables, artwork, cover letter, 
conflicts of interest disclosures, and any other 
required documents/material) must be submitted 
online to GMIT through the Elsevier Editorial System 
(EES) at http://ees.elsevier.com/gmit. If assistance is 
required, please refer to the tutorials for authors and/
or customer support that are available on the EES 
website; you may also contact the Editorial Office. 
Please do not post, fax or e-mail your manuscripts to 
the Editorial Office.
Editorial Office
Gynecology and Minimally Invasive Therapy (GMIT)
APAGE 
No. 5, Fuxing Street, Guishan Township, Taoyuan 
County 333, Taiwan
Tel: (+886) 3-328-1200 ext. 8253
Fax: (+886) 3-328-6700
E-mail: gmit.apage@gmail.com
1.1. Important Information
•	 	Articles should be in Microsoft Word document 
format and prepared in the simplest form possible. 
We will add in the correct font, font size, margins 
and so on according to the Journal’s style.
•	 	You may use automatic page numbering, but do 
NOT use other kinds of automatic formatting such as 
footnotes, headers and footers. References especially 
should NOT be formatted using the MS Word 
“endnotes” or “footnotes” function; instead, you may 
use the commercially available EndNote® or Reference 
Manager® software to manage your references.
•	 	Put text, references, table headings and tables, and 
figure legends in one file.
•	 	Figures must be submitted as separate picture files, 
at the correct resolution and named according to the 
figure number and format, e.g., “Fig1.tif”, “Fig2.jpg”. 
Please see section 9.8. for more information.
1.2. Supporting Documents
The following documents must be included in your 
submission (refer also to the Checklist that follows 
these author instructions). Items (1), (2) and (3) are 
mandatory. Items (4), (5), (6) and (7) are required 
only if they are applicable to your manuscript.
(1)  Cover Letter. This must include the title of the 
manuscript, the name, address, telephone and fax 
numbers, and e-mail address of the corresponding 
author. The letter must state that the material 
contained in the manuscript has not been previously 
published and is not being concurrently submitted 
elsewhere. A manuscript that has been previously 
submitted but rejected by another journal will be 
considered if it has been revised, provided that this is 
stated in the cover letter. Make a note in the letter of 
manuscripts that have been published, submitted, or 
are in press that are similar to the submission to GMIT, 
and include in your submission copies of those similar 
manuscripts so that the editors can be assured there 
is no overlap. Your signature and those of ALL your 
coauthors must be included on the cover letter.
(2)  Authorship & Conflicts of Interest Statement. Each 
author’s contribution to the manuscript should be 
listed. Any and all potential and actual conflicts 
of interest should also be listed (see Section 2 for 
more information). Please use the GMIT Authorship 
& Conflicts of Interest Statement form that follows 
these author instructions and that is also provided 
on the Journal’s website at www.e-gmit.com. The 
corresponding author must sign the statement on 
behalf of all the authors listed in the manuscript.
(3)  Copyright Transfer Agreement. You are required to 
transfer all copyright ownership in and relating to 
the work to APAGE. Please use the GMIT Copyright 
Transfer Agreement form that follows these 
author instructions and that is also provided on 
the Journal’s website at www.e-gmit.com. Your 
signature and those of ALL your coauthors must be 
included. However, the Agreement will be null and 
void if your manuscript is not published in GMIT.
(4)  Ethics Statement. Articles covering the use of human 
or animal samples in research, or human or animal 
experiments must be accompanied by a letter of 
approval from the relevant review committee or 
authorities. See Section 3 for more information.
(5)  Consolidated Standards of Reporting Trials 
(CONSORT) flow chart for randomized controlled 
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trials submitted for publication. See Section 4 for 
more information.
(6)  Signed Statement of Informed Consent. Articles 
where human subjects can be identified in 
descriptions, photographs or pedigrees must be 
accompanied by a signed statement of informed 
consent to publish (in print and online) the 
descriptions, photographs and pedigrees from each 
subject who can be identified. See Section 5 for 
more information.
(7)  Copyright Permission. If you have reproduced or 
adapted material from other copyrighted sources, 
the letter(s) of permission from the copyright 
holder(s) to reproduce or adapt the copyrighted 
sources must be supplied. Otherwise, such material 
must be removed from your manuscript.
2. Disclosure of conflicts of Interest
A conflict of interest occurs when an individual’s 
objectivity is potentially compromised by a desire for 
financial gain, prominence, professional advancement 
or a successful outcome. The editors of GMIT strive 
to ensure that what is published in the Journal is as 
balanced, objective and evidence-based as possible. 
Since it can be difficult to distinguish between an actual 
conflict of interest and a perceived conflict of interest, 
the Journal requires authors to disclose all and any 
potential conflicts of interest.
Conflicts of interest may be financial or non-
financial. Financial conflicts include financial 
relationships such as honoraria; educational grants; 
participation in speakers’ bureaus; membership, 
employment, consultancies, stock ownership, or other 
equity interest; expert testimony or patent-licensing 
arrangements. Non-financial conflicts include personal 
or professional relationships, affiliations, academic 
competition, intellectual passion, knowledge or beliefs 
that might affect objectivity.
Please note that using the new GMIT AS-COI form 
means that authors will not need to submit the ICMJE 
form anymore.
3.  Ethical Approval of Studies and 
Informed consent
For human or animal experimental investigations, 
appropriate institutional review board or ethics 
committee approval is required, and such approval should 
be stated in the methods section of the manuscript. For 
those investigators who do not have formal ethics review 
committees, the principles outlined in the Declaration of 
Helsinki should be followed (World Medical Association. 
Declaration of Helsinki: Ethical Principles for Medical 
Research Involving Human Subjects. Available at: http://
www.wma.net/en/30publications/10policies/b3/17c.pdf).
For investigation of human subjects, state explicitly 
in the methods section of the manuscript that informed 
consent was obtained from all participating adult 
subjects and from parents or legal guardians for minors 
or incapacitated adults, together with the manner in 
which informed consent was obtained (e.g., oral or 
written).
For work involving animals, the guidelines for 
their care and use should be in accordance with 
European Commission Directive 86/609/EEC for 
Animal Experiments (available at http://ec.europa.
eu/environment/chemicals/lab_animals/legislation_
en.htm); this should be stated in the methods section 
of the manuscript.
4. reporting clinical trials
All randomized controlled trials submitted for 
publication should include a completed Consolidated 
Standards of Reporting Trials (CONSORT) flow chart 
(please go to http://www.consort-statement.org for 
more information). GMIT has adopted the ICMJE 
proposal that requires, as a condition of consideration 
for publication of clinical trials, registration in a public 
trials registry. Purely observational studies (those in 
which the assignment of the medical intervention is 
not at the discretion of the investigator) will not require 
registration. Further information can be found at 
http://www.icmje.org.
5.  Identification of Patients in 
Descriptions, Photographs and 
Pedigrees
A signed statement of informed consent to publish (in 
print and online) patient descriptions, photographs and 
pedigrees should be obtained from all persons (parents 
or legal guardians for minors) who can be identified 
(including by the patients themselves) in such written 
descriptions, photographs or pedigrees. Such persons 
should be shown the manuscript before its submission. 
Omitting data or making data less specific to de-identify 
patients is acceptable, but changing any such data is not 
acceptable.
State explicitly in the methods section of the 
manuscript that informed consent was obtained from 
all participating adult subjects or from parents or legal 
guardians for minors or incapacitated adults, together 
with the manner in which informed consent was 
obtained (i.e., oral or written).
6.  Previous Publication or Duplicate 
Submission
Submitted manuscripts are considered with the 
understanding that they have not been published 
previously in print or electronic format (except in 
abstract or poster form) and are not under consideration 
in totality or in part by another publication or electronic 
medium.
7. Basic criteria
Articles should be written in English, using American 
English spelling, and meet the following basic criteria: 
the material is original, the information is important, 
the writing is clear and concise, the study methods are 
appropriate, the data are valid, and the conclusions are 
reasonable and supported by the data.
8. Article categories
8.1. Editorials
Editorials are invited articles or comments concerning a 
specific paper in the Journal. They should be limited to 
1200 words with no more than 15 references. Although 
editorials are normally invited, unsolicited editorials 
may be submitted.
8.2. Review Articles
These should aim to provide the reader with a balanced 
overview of an important and topical subject in the 
field. They should cover aspects of a topic in which 
scientific consensus exists as well as aspects that remain 
controversial and are the subject of ongoing scientific 
research. All articles and data sources reviewed should 
include information about the specific type of study or 
analysis, population, intervention, exposure, and tests 
or outcomes. All articles or data sources should be 
selected systematically for inclusion in the review and 
critically evaluated.
Typical length: 3500–4000 words; 40–60 
references; up to 6 tables and/or figures.
8.3. Original Articles
These articles typically include randomized trials, 
intervention studies, studies of screening and diagnostic 
tests, laboratory and animal studies, cohort studies, 
cost-effectiveness analyses, case-control studies, and 
surveys with high response rates, which represent 
new and significant contributions to the field. Section 
headings should be: Abstract, Introduction, Materials 
and Methods, Results, Discussion, Conflicts of Interest 
Statement (if any), Acknowledgments (if any), and 
References.
Typical length: 2000–4000 words; 20–50 
references; up to 6 tables and/or figures.
8.4. Short Communications
These reports should be concise presentations of 
research results or novel techniques or use of equipment, 
pioneering instruments, or advanced surgical skills.
Typical length: 2000 words; 10 references; up to 4 
tables and/or figures.
The Editors reserve the right to decide what 
constitutes a Short Communication.
8.5. Case Reports
These are short discussions of a case or case series with 
unique features not previously described that make 
an important teaching point or scientific observation. 
They may describe rare cases, complications or 
morbidities from an educational perspective, or new 
information on diseases of interest. Section headings 
should be: Abstract, Introduction, Case Report, 
Discussion, Conflicts of Interest Statement (if any), 
Acknowledgments (if any), and References.
Typical length: 1500 words; 10 references; up to 2 
tables and/or figures.
8.6. Clinical Images
These comprise clinical images, photographs or 
diagnostic tests with educational value (such 
as ultrasound scans, MRI films, endoscopic 
photographs, histopathology, immunohistochemistry, 
photomicrographs, DNA blots, or pictures of molecular 
studies). The report should be of a specific case and 
focus on the image(s).
Typical length: 800 words; 6 references; up to 4 
figures; there should be no more than 4 authors. The 
use of multimedia components such as additional 
images or video clips is acceptable.
8.7. Letters to the Editor
Letters are welcome in response to previously published 
GMIT articles, and may also include interesting cases that 
do not meet the requirement of being truly exceptional, 
as well as other communications of general interest. 
Letters should have a title and include appropriate 
references, and include the author’s mailing and e-mail 
addresses. Letters are edited, sometimes extensively, to 
sharpen their focus. They may be sent for peer review at 
the discretion of the Editors. Letters are selected based 
on clarity, significance, and space. The text should not 
exceed 350 words.
9. Manuscript Preparation
Text should be typed double-spaced on white 
A4 (297  210 mm) paper, with outer margins of 
2.5 cm. A manuscript should include a title page, 
abstract, text, conflicts of interest statement (if any), 
acknowledgments (if any), references, and figures and 
tables as appropriate. Each section of the manuscript 
should begin on a new page. Pages should be numbered 
consecutively, beginning with the title page.
9.1. Title Page
The title page should contain the following information 
(in order, from the top to bottom of the page):
•	 article	category
•	 article	title
•	 	names	 (spelled	out	 in	 full)	of	 all	 authors*,	 and	 the	
institutions with which they are affiliated; indicate 
all affiliations with a superscripted lowercase letter 
after the author’s name and in front of the matching 
affiliation
•	 conflicts	of	 interest	declaration;	 if	none,	 then	state	
"The author(s) have no conflicts of interest relevant 
to this article."
•	 corresponding	author	details	(name,	e-mail,	mailing	
address, telephone and fax numbers)
•	 word	counts	of	abstract	and	main	text
*The name of each author should be written with the 
family name last, e.g., Wan-Lin Chang. Authorship is 
restricted only to direct participants who have contributed 
significantly to the work.
9.2. Abstracts and Keywords
An abstract and 3–5 relevant keywords (in 
alphabetical order) are required for the following 
article categories: Review Articles, Original Articles, 
Short Communications, and Case Reports.
Abstracts for Original Articles and Short 
Communications should be structured, with the 
section headings: Objective, Materials and Methods, 
Results, and Conclusion. Abstracts for Original Articles 
should be no longer than 250 words and that of Short 
Communications no longer than 200 words.
Abstracts for Review Articles should be 
unstructured, in one single paragraph of no more 
than 250 words in length that clearly summarize the 
main findings.
Abstracts for Case Reports should be unstructured, 
in one single paragraph of not more than 150 words, 
but should include the significance and purpose 
of the case presentation, the diagnostic methods 
of the case, the key data, and brief comments and 
suggestions with regard to the case.
An abstract is often presented separately from 
the article, so it must be able to stand alone. For 
this reason, References should be avoided, but if 
essential, then cite the author(s) and year(s). Also, 
non-standard or uncommon abbreviations should be 
avoided, but if essential they must be defined at their 
first mention in the abstract itself.
Keywords will be used for indexing purposes and 
should be taken from the Medical Subject Headings 
(MeSH) list of Index Medicus (www.nlm.nih.gov/
mesh/meshhome.html). Avoid general and plural 
terms and multiple concepts (avoid, for example, 
“and”, “of”). Be sparing with abbreviations: only 
abbreviations firmly established in the field may be 
eligible.
No abstract or keywords are required for the 
following article categories: Editorials, Clinical 
Images, and Letters to the Editor.
9.3. Main Text
9.3.1. Section headings
The text for Original Articles and Short Communications 
should be organized into the following sections: 
Introduction, Materials and Methods, Results, and 
Discussion.
The Introduction should provide a brief background 
to the subject of the paper, explain the importance of 
the study, and state a precise study question or purpose. 
The Materials and Methods section should describe the 
study design and methods (including the study setting 
and dates, patients/participants with inclusion and 
exclusion criteria, patient samples or animal specimens 
used, the essential features of any interventions, the 
main outcome measures, the laboratory methods 
followed, or data sources and how these were selected 
for the study), and state the statistical procedures 
employed in the research.
The Results section should comprise the study 
results presented in a logical sequence, supplemented 
by tables and/or figures. Take care that the text does not 
repeat data that are presented in tables and/or figures. 
Only emphasize and summarize the essential features 
of the main results. The Discussion section should be 
used to emphasize the new and important aspects of 
the study, placing the results in context with published 
literature, the implications of the findings, and the 
conclusions that follow from the study results.
Sections for Case Reports should be: Introduction, 
Case Report, and Discussion. Each section should begin 
on a new page. The Introduction should describe the 
purpose of the present report, the significance of 
the disease and its specificity, and briefly review the 
relevant literature. The Case Report should include the 
general data of the case, medical history, family history, 
chief complaint, present illness, clinical manifestation, 
methods of diagnosis and treatment, and outcome. The 
Discussion should compare, analyze and discuss the 
similarities and differences between the reported case 
and similar cases reported in other published articles. 
The importance or specificity of the case should be 
restated when discussing the differential diagnoses. 
Suggest the prognosis of the disease and possibility of 
prevention.
9.3.2. Abbreviations
Where a term/definition will be continually referred 
to, it must be written in full when it first appears in 
the text, followed by the subsequent abbreviation in 
parentheses. Thereafter, the abbreviation may be used. 
An abbreviation should not be first defined in any 
section heading; if an abbreviation has previously been 
defined in the text, then the abbreviation may be used 
in a subsequent section heading. Restrict the number 
of abbreviations to those that are absolutely necessary.
9.3.3. Numbers
Numbers that begin a sentence or those that are less 
than 10 should be spelled out using letters. Centuries 
and decades should be spelled out, e.g., the Eighties 
or nineteenth century. Laboratory parameters, time, 
temperature, length, area, mass, and volume should be 
expressed using digits.
9.3.4. Units
Système International (SI) units must be used, with 
the exception of blood pressure values which are 
to be reported in mmHg. Use the metric system for 
the expression of length, area, mass, and volume. 
Temperatures are to be given in degrees Celsius.
9.3.5. Names of drugs, devices and other products
Use the Recommended International Non-proprietary 
Name (rINN) for medicinal substances, unless the specific 
trade name of a drug is directly relevant to the discussion. 
Generic drug names should appear in lowercase letters 
in the text. If a specific proprietary drug needs to be 
identified, the brand name may appear only once in the 
manuscript in parentheses following the generic name 
the first time the drug is mentioned in the text.
For devices and other products, the specific brand 
or trade name, the manufacturer and their location 
(city, state, country) should be provided the first time 
the device or product is mentioned in the text, for 
example, “…IBM SPSS Statistics 21.0 was used (IBM 
Corp., Armonk, NY, USA)”. Thereafter, the generic 
term (if appropriate) should be used.
9.3.6. Statistical requirements
Statistical analysis is essential for all research papers 
except Case Reports. Use correct nomenclature for 
statistical methods (e.g., two sample t test, not unpaired t 
test). Descriptive statistics should follow the scales used 
in data description. Inferential statistics are important 
for interpreting results and should be described in detail.
All p values should be presented to the third decimal 
place for accuracy. The smallest p value that should 
be expressed is p < 0.001 since additional zeros do not 
convey useful information; the largest p value that should 
be expressed is p > 0.99.
9.3.7. Personal communications and unpublished 
data
These sources cannot be included in the references list 
but may be described in the text. The author(s) must give 
the full name and highest academic degree of the person, 
the date of the communication, and indicate whether it 
was in oral or written (letter, fax, e-mail) form. A signed 
statement of permission should be included from each 
person identified as a source of information in a personal 
communication or as a source for unpublished data.
9.4. Acknowledgments
After the main text, general acknowledgments for 
consultations and statistical analyses should be listed 
concisely, including the names of the individuals who 
were directly involved. Consent should be obtained 
from those individuals before their names are listed in 
this section. All financial and material support for the 
research, work, writing and editorial assistance from 
internal or external agencies, including commercial 
companies, should be clearly and completely identified.
9.5. References
Authors are responsible for the accuracy and 
completeness of their references and for correct in-text 
citation.
9.5.1. In the main text, tables and figure legends
•	 References	should	be	identified	using	superscripted	
numbers, and numbered consecutively in order of 
appearance.
•	 The	superscripted	numbers	should	be	placed	outside 
periods and commas, and placed inside colons and 
semicolons.
•	 References	 cited	 in	 tables	or	 figure	 legends	 should	
be included in sequence at the point where the table 
or figure is first mentioned in the main text.
•	 Do	 not	 cite	 abstracts	 unless	 they	 are	 the	 only	
available reference to an important concept.
•	 Do	not	cite	uncompleted	work	or	work	that	has	not	
yet been accepted for publication (i.e., “unpublished 
observation”, “personal communication”) as 
references. Also see Section 9.3.7.
9.5.2. In the references list
•	 References	 should	 be	 compiled	 at	 the	 end	 of	 the	
manuscript according to the order of citation in 
the text and should follow the American Medical 
Association (AMA) style and format.
•	 References	 should	 be	 limited	 to	 those	 cited	 in	 the	
text only.
•	 Journal	references	should	include,	in	order,	authors’	
surnames and initials, article title, abbreviated 
journal name, year, volume and inclusive page 
numbers.
•	 The	surnames	and	initials	of	all	the	authors	up	to	6	
should be included, but when authors number 7 or 
more, list the first 3 authors only followed by “et al”.
•	 Abbreviations	for	journal	names	should	conform	to	
those used in MEDLINE.
•	 If	citing	a	website,	provide	the	author	 information,	
article title, website address and the date you 
accessed the information.
•	 Reference	to	an	article	that	is	in	press	must	state	the	
journal name and, if possible, the year and volume.
Examples of the most common reference types are 
provided below. (Please pay particular attention to the 
formatting, word capitalization, spacing and style.)
Standard journal article
Chen Z, Fan M, Bian Z, Zhang Q, Zhu Q, Lu P. 
Immunolocalization of heat shock protein 70 during 
reparative dentinogenesis. Chin J Dent Res. 2000;3:50–55.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and 
therapeutic target: what criteria should we apply? 
J Cardiovasc Pharmacol. 1998;32(Suppl 3):S78–80.
Journal article not in English but with English abstract
Kawai H, Ishikawa T, Moroi J, et al. Elderly patient with 
cerebellar malignant astrocytoma. No Shinkei Geka. 
2008;36:799–805. [In Japanese, English abstract]
Book with edition
Bradley EL. Medical and Surgical Management. 2nd ed. 
Philadelphia, PA: Saunders; 1982.
Book with editors
Letheridge S, Cannon CR, eds. Bilingual Education: 
Teaching English as a Second Language. New York, NY: 
Praeger; 1980.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: 
Underwood JCE, ed. General and Systematic Pathology. 
4th ed. London: Churchill Livingstone; 2004:615–672.
Book series with editors
Wilson JG, Fraser FC, eds. Handbook of Teratology, Vols. 
1–4. New York, NY: Plenum Press; 1977–1978.
Bulletin
World Health Organization. World Health Report 
2002: Reducing Risk, Promoting Healthy Life. Geneva, 
Switzerland: World Health Organization; 2002.
Electronic publications
Duchin JS. Can preparedness for biological terrorism save 
us from pertussis? Arch Pediatr Adolesc Med. 2004;158(2). 
Available at http://archpedi.ama-assn.org/cgi/content/
full/158/2/106. Accessed June 12, 2004.
Smeeth L, Iliffe S. Community screening for visual 
impairment in the elderly. Cochrane Database Syst Rev. 
2002(2):CD001054. Doi:10.1002/14651858.CD1001054.
Item presented at a meeting but not yet published
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on head 
and neck cancer recurrence and second primary tumors. 
In: Proceedings from the American Society of Clinical 
Oncology, May 31–June 3, 2003; Chicago, IL. Abstract 359.
Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or 
bluelight-filtering IOLs. In: Symposium on Cataract, IOL, 
and Refractive Surgery. San Diego, CA: American Society 
of Cataract and Refractive Surgery; 2004. Abstract 337.
Thesis
Ayers AJ. Retention of Resin Restorations by Means of Enamel 
Etching and by Pins. MSD thesis, Indiana University, 
Indianapolis, 1971.
Website
American Association of Oral and Maxillofacial Surgeons. 
Wisdom Teeth. Rosemont, IL: AAOMS, 2008. Available at 
http://www.aaoms.org/wisdom_teeth.php. Accessed 
November 15, 2008.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog No. 49. Rochester, NY: Eastman Kodak; 1977:2–3.
9.6. Tables
Tables should supplement, not duplicate, the text. They 
should have a concise table heading, be self-explanatory, 
and numbered consecutively in the order of their citation 
in the text. Items requiring explanatory footnotes should 
be denoted using superscripted lowercase letters (a, 
b, c, etc.), with the footnotes arranged under the table 
in	 alphabetical	 order.	Asterisks	 (*,	 **)	 are	used	only	 to	
indicate the probability level of tests of significance. 
Abbreviations used in the table must be defined and 
placed after the footnotes in alphabetical order. If 
you include a block of data or table from another 
source, whether published or unpublished, you must 
acknowledge the original source.
9.7. Figures
9.7.1. General guidelines
The number of figures should be restricted to the min-
imum necessary to support the textual material. 
Figures should have an informative figure legend and 
be numbered in the order of their citation in the text. 
All symbols and abbreviations should be defined in the 
legend in alphabetical order. Patient identification 
should be obscured. All lettering should be done pro-
fessionally and should be in proportion to the drawing, 
graph or photograph. Photomicrographs must include 
an internal scale marker, and the legend should state 
the type of specimen, original magnification and stain.
Figures must be submitted as separate picture files, 
at the correct resolution (see Section 9.7.2.) and named 
according to the figure number and format, e.g., “Fig1.
tif”, “Fig2.jpg”.
9.7.2. Formats
Regardless of the application used, when your elec-
tronic artwork is finalized, please “save as” or convert 
the images to one of the following formats (note the 
resolution requirements for line drawings, halftones, 
and line/halftone combinations given below):
•	 EPS:	 vector	 drawings.	 Embed	 the	 font	 or	 save	 the	
text as “graphics”.
•	 TIFF:	 color	 or	 grayscale	 photographs	 (halftones)—
use a minimum of 300 dpi.
•	 TIFF:	bitmapped	 line	drawings—use	a	minimum	of	
1000 dpi.
•	 TIFF:	combination	of	bitmapped	line/halftone	(color	
or	grayscale)—use	a	minimum	of	600	dpi.
•	 DOC,	XLS	or	PPT:	if	your	electronic	artwork	is	created	
in any of these Microsoft Office applications, please 
supply “as is”.
Please do not:
•	 Supply	 files	 that	 do	 not	 meet	 the	 resolution	
requirements detailed above;
•	 Supply	files	that	are	optimized	for	screen	use	(such	
as GIF, BMP, PICT, WPG) as the resolution is too low;
•	 Submit	graphics	that	are	disproportionately	large	for	
the content.
A detailed guide on electronic artwork is available 
at http://www.elsevier.com/artworkinstructions. Please 
note that the cost of color illustrations will be charged to 
the author.
10.  the Editorial and Peer review Process
As a general rule, the receipt of a manuscript will be 
acknowledged within 2 weeks of submission, and 
authors will be provided with a manuscript reference 
number for future correspondence. If such an 
acknowledgment is not received in a reasonable period 
of time, the author should contact the Editorial Office.
Submissions are reviewed by the Editorial Office 
to ensure that it contains all parts. Submissions 
will be rejected if the author has not supplied all 
the material and documents as outlined in these author 
instructions.
Manuscripts are then forwarded to the Editor-in-
Chief, who makes an initial assessment of it. If the 
manuscript does not appear to be of sufficient merit or 
is not appropriate for the Journal, then the manuscript 
will be rejected without review. Rejected manuscripts 
will not be returned to authors unless requested.
Manuscripts that appear meritorious and appropriate 
for the Journal are reviewed by at least two Editorial 
Board members or expert consultants assigned by 
the Editor-in-Chief. These peer reviewers will remain 
anonymous and may or may not be the reviewers 
suggested by the author(s) as the selection of reviewers 
is at the sole discretion of GMIT editors. The editors and 
reviewers will not disclose any information about a 
manuscript or its review to anyone.
The corresponding author will usually be notified 
within 10 weeks of whether the submitted article is 
accepted for publication, rejected, or subject to revision 
before acceptance (however, do note that delays are 
sometimes unavoidable). If revisions are required, 
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